Skip to main content
. 2023 Apr 24;38(10):2358–2367. doi: 10.1093/ndt/gfad074

Figure 2:

Figure 2:

Mean change in hemoglobin from baseline during the primary and secondary evaluation periods in patients receiving peritoneal dialysis at baseline in the INNO2VATE trials (randomized population). DA, darbepoetin alfa; LS, least squares; VADA, vadadustat.